Show simple item record

dc.contributor.authorPorter, T.
dc.contributor.authorBurnham, S.
dc.contributor.authorSavage, G.
dc.contributor.authorLim, Y.
dc.contributor.authorMaruff, P.
dc.contributor.authorMilicic, L.
dc.contributor.authorPeretti, M.
dc.contributor.authorAmes, D.
dc.contributor.authorMasters, C.
dc.contributor.authorMartins, R.
dc.contributor.authorRainey-Smith, S.
dc.contributor.authorRowe, C.
dc.contributor.authorSalvado, O.
dc.contributor.authorTaddei, K.
dc.contributor.authorGroth, David
dc.contributor.authorVerdile, Giuseppe
dc.contributor.authorVillemagne, V.
dc.contributor.authorLaws, Simon
dc.date.accessioned2019-03-15T00:02:12Z
dc.date.available2019-03-15T00:02:12Z
dc.date.issued2018
dc.identifier.citationPorter, T. and Burnham, S.C. and Savage, G. and Lim, Y.Y. and Maruff, P. and Milicic, L. and Peretti, M. et al. 2018. A Polygenic Risk Score Derived From Episodic Memory Weighted Genetic Variants Is Associated With Cognitive Decline in Preclinical Alzheimer's Disease. Frontiers in Aging Neuroscience. 10: 423.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/75016
dc.identifier.doi10.3389/fnagi.2018.00423
dc.description.abstract

Studies of Alzheimer's disease risk-weighted polygenic risk scores (PRSs) for cognitive performance have reported inconsistent associations. This inconsistency is particularly evident when PRSs are assessed independent of APOE genotype. As such, the development and assessment of phenotype-specific weightings to derive PRSs for cognitive decline in preclinical AD is warranted. To this end a episodic memory-weighted PRS (emPRS) was derived and assessed against decline in cognitive performance in 226 healthy cognitively normal older adults with high brain Aβ-amyloid burden participants from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study. The effect size for decline in a verbal episodic memory was determined individually for 27 genetic variants in a reference sample (n = 151). These were then summed to generate a emPRS either including APOE (emPRSc̅APOE) or excluding APOE (emPRSs̅APOE ). Resultant emPRS were then evaluated, in a test sample (n = 75), against decline in global cognition, verbal episodic memory and a pre-Alzheimer's cognitive composite (AIBL-PACC) over 7.5 years. The mean (SD) age of the 226 participants was 72.2 (6.6) years and 116 (51.3%) were female. Reference and test samples did not differ significantly demographically. Whilst no association of emPRSs were observed with baseline cognition, the emPRSc̅ APOE was associated with longitudinal global cognition (-0.237, P = 0.0002), verbal episodic memory (-0.259, P = 0.00003) and the AIBL-PACC (-0.381, P = 0.02). The emPRSs̅ APOE was also associated with global cognition (-0.169, P = 0.021) and verbal episodic memory (-0.208, P = 0.004). Stratification by APOE ε4 revealed that the association between the emPRS and verbal episodic memory was limited to carriage of no ε4 or one ε4 allele. This was also observed for global cognition. The emPRS and rates of decline in AIBL-PACC were associated in those carrying one ε4 allele. Overall, the described novel emPRS has utility for the prediction of decline in cognition in preclinical AD. This study provides evidence to support the further use and evaluation of phenotype weightings in PRS development.

dc.languageEnglish
dc.publisherFRONTIERS MEDIA SA
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectScience & Technology
dc.subjectLife Sciences & Biomedicine
dc.subjectGeriatrics & Gerontology
dc.subjectNeurosciences
dc.subjectNeurosciences & Neurology
dc.subjectpolygenic risk score
dc.subjectAlzheimer's disease
dc.subjectA beta-amyloid
dc.subjectcognitive decline
dc.subjectepisodic memory
dc.subjectTRANSCRIPTION FACTOR
dc.subjectIMPAIRMENT
dc.subjectBETA
dc.subjectINDIVIDUALS
dc.subjectPREDICTION
dc.subjectBIOMARKERS
dc.subjectPROTEIN
dc.subjectMEF2C
dc.titleA Polygenic Risk Score Derived From Episodic Memory Weighted Genetic Variants Is Associated With Cognitive Decline in Preclinical Alzheimer's Disease
dc.typeJournal Article
dcterms.source.volume10
dcterms.source.issn1663-4365
dcterms.source.titleFrontiers in Aging Neuroscience
dc.date.updated2019-03-15T00:02:01Z
curtin.departmentSchool of Pharmacy and Biomedical Sciences
curtin.accessStatusOpen access
curtin.facultyFaculty of Health Sciences
curtin.identifier.article-numberARTN 423
dcterms.source.eissn1663-4365


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/